Is intravenous thrombolysis feasible in a developing country?
Pandian
Jeyaraj Durai
JD
Stroke Unit, Department of Neurology, Christian Medical College, Ludhiana, India. jeyarajpandian@yahoo.co.in
Sethi
Vineeta
V
Dhillon
Robinderjeet
R
Kaur
Ravneet
R
Padala
Smita
S
Chakravorty
Rajesh
R
Singh
Yashpal
Y
D000328:Adult; D000367:Age Factors; D000368:Aged; D003906:Developing Countries; D005006:Ethnicity; D006801:Humans; D008875:Middle Aged; D010960:Plasminogen Activators / Q000008:administration & dosage / Q000627:therapeutic use; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000627:therapeutic use; D012737:Sex Factors; D012959:Socioeconomic Factors; D015912:Thrombolytic Therapy; D010959:Tissue Plasminogen Activator / Q000008:administration & dosage / Q000627:therapeutic use
D011994:Recombinant Proteins; D010960:Plasminogen Activators; D010959:Tissue Plasminogen Activator